Utility of hydroxyurea in mast cell activation syndrome.
about
Pharmacological treatment options for mast cell activation diseaseMast Cell Activation SyndromeMast cell activation syndrome as a significant comorbidity in sickle cell disease.Anaphylaxis as a clinical manifestation of clonal mast cell disorders.Insights in Anaphylaxis and Clonal Mast Cell Disorders.
P2860
Utility of hydroxyurea in mast cell activation syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utility of hydroxyurea in mast cell activation syndrome.
@en
Utility of hydroxyurea in mast cell activation syndrome.
@nl
type
label
Utility of hydroxyurea in mast cell activation syndrome.
@en
Utility of hydroxyurea in mast cell activation syndrome.
@nl
prefLabel
Utility of hydroxyurea in mast cell activation syndrome.
@en
Utility of hydroxyurea in mast cell activation syndrome.
@nl
P2860
P356
P1476
Utility of hydroxyurea in mast cell activation syndrome.
@en
P2093
Lawrence B Afrin
P2860
P2888
P356
10.1186/2162-3619-2-28
P577
2013-10-09T00:00:00Z
P5875
P6179
1037587746